| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
32,003 |
28,082 |
$1.92M |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
7,197 |
2,624 |
$894K |
| 99070 |
|
27,460 |
10,691 |
$576K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
6,051 |
5,514 |
$535K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
809 |
803 |
$511K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,828 |
1,768 |
$492K |
| 70450 |
Computed tomography, head or brain; without contrast material |
2,024 |
1,983 |
$471K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
8,052 |
7,451 |
$364K |
| J3490 |
Unclassified drugs |
17,034 |
7,665 |
$307K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
3,834 |
3,440 |
$241K |
| 99199 |
Unlisted special service, procedure or report |
3,388 |
2,863 |
$227K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
178 |
178 |
$213K |
| 97139 |
|
11,659 |
3,003 |
$210K |
| 0450 |
Emergency room services |
3,604 |
3,197 |
$205K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
2,381 |
2,345 |
$203K |
| 99221 |
|
492 |
363 |
$193K |
| 72141 |
|
276 |
275 |
$189K |
| 66984 |
Extracapsular cataract removal with insertion of intraocular lens prosthesis |
303 |
279 |
$178K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
294 |
291 |
$171K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
354 |
346 |
$170K |
| 80053 |
Comprehensive metabolic panel |
13,512 |
12,366 |
$163K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
843 |
619 |
$154K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
3,475 |
3,205 |
$128K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
15,660 |
14,206 |
$118K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
760 |
754 |
$115K |
| 86480 |
|
1,461 |
1,392 |
$111K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
1,248 |
1,206 |
$111K |
| 71045 |
Radiologic examination, chest; single view |
5,752 |
5,458 |
$107K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
1,409 |
1,335 |
$103K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
1,486 |
1,452 |
$97K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,479 |
2,330 |
$95K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,498 |
1,425 |
$94K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
739 |
706 |
$80K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
288 |
285 |
$74K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
2,835 |
2,533 |
$72K |
| 82274 |
|
4,355 |
4,353 |
$63K |
| 71046 |
Radiologic examination, chest; 2 views |
2,180 |
2,120 |
$63K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
238 |
237 |
$62K |
| 84484 |
|
6,055 |
5,506 |
$62K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
2,934 |
2,637 |
$56K |
| A9579 |
Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml |
896 |
872 |
$49K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
1,645 |
711 |
$49K |
| 83690 |
|
6,287 |
5,884 |
$46K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
3,701 |
3,565 |
$45K |
| 0250 |
|
4,457 |
1,414 |
$43K |
| 73221 |
|
91 |
87 |
$42K |
| 97750 |
|
1,007 |
746 |
$40K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
2,775 |
2,658 |
$39K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,152 |
971 |
$37K |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
536 |
409 |
$37K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
114 |
113 |
$36K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,088 |
1,071 |
$35K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
4,738 |
4,284 |
$33K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,088 |
1,071 |
$32K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
390 |
384 |
$31K |
| 86703 |
|
1,752 |
1,687 |
$28K |
| T1999 |
Miscellaneous therapeutic items and supplies, retail purchases, not otherwise classified; identify product in "remarks" |
1,843 |
809 |
$26K |
| 73030 |
|
640 |
632 |
$23K |
| 76000 |
|
675 |
630 |
$22K |
| 86803 |
|
1,486 |
1,422 |
$22K |
| 77080 |
|
574 |
563 |
$22K |
| 83605 |
|
1,642 |
1,525 |
$21K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
250 |
245 |
$20K |
| 82962 |
|
2,878 |
2,226 |
$20K |
| 81025 |
|
5,260 |
4,905 |
$20K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,063 |
1,051 |
$19K |
| V2632 |
Posterior chamber intraocular lens |
90 |
87 |
$18K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
580 |
546 |
$18K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
206 |
202 |
$18K |
| 81003 |
|
8,073 |
7,682 |
$17K |
| 11045 |
|
576 |
262 |
$17K |
| 87088 |
|
2,840 |
2,744 |
$16K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
334 |
333 |
$16K |
| V2630 |
Anterior chamber intraocular lens |
150 |
138 |
$15K |
| 83880 |
|
589 |
557 |
$14K |
| 73562 |
|
424 |
416 |
$14K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
1,402 |
1,146 |
$14K |
| 76830 |
Ultrasound, transvaginal |
152 |
152 |
$14K |
| 36415 |
Collection of venous blood by venipuncture |
1,970 |
1,657 |
$14K |
| 72100 |
|
388 |
385 |
$12K |
| 83735 |
|
1,665 |
1,571 |
$11K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
1,019 |
935 |
$11K |
| 73564 |
|
295 |
275 |
$10K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
689 |
324 |
$10K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,103 |
956 |
$10K |
| 87400 |
|
553 |
520 |
$9K |
| 87040 |
|
603 |
564 |
$9K |
| 73630 |
|
294 |
290 |
$8K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,051 |
1,013 |
$8K |
| 87081 |
|
1,354 |
1,303 |
$8K |
| 81001 |
|
2,381 |
2,296 |
$8K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
834 |
786 |
$8K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
243 |
233 |
$8K |
| 73130 |
|
225 |
220 |
$7K |
| 70498 |
|
25 |
25 |
$7K |
| 72170 |
|
292 |
288 |
$7K |
| 85027 |
|
1,030 |
887 |
$6K |
| 73610 |
|
149 |
147 |
$6K |
| 97597 |
|
120 |
91 |
$5K |
| 87490 |
|
194 |
185 |
$5K |
| 87634 |
|
87 |
84 |
$5K |
| 93308 |
|
24 |
24 |
$5K |
| 84702 |
|
430 |
407 |
$5K |
| 85610 |
|
1,322 |
1,243 |
$5K |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
696 |
650 |
$5K |
| 85379 |
|
415 |
409 |
$4K |
| 87590 |
|
194 |
185 |
$4K |
| 99218 |
|
129 |
119 |
$4K |
| 87186 |
|
594 |
555 |
$4K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
464 |
452 |
$4K |
| 84466 |
|
348 |
333 |
$4K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
506 |
466 |
$3K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
475 |
460 |
$3K |
| 70496 |
|
13 |
13 |
$3K |
| 85730 |
|
450 |
438 |
$3K |
| 87341 |
|
295 |
295 |
$3K |
| 87077 |
|
429 |
407 |
$3K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
322 |
317 |
$2K |
| J7324 |
Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose |
46 |
45 |
$2K |
| 82803 |
|
181 |
173 |
$2K |
| 97799 |
|
252 |
78 |
$2K |
| 73110 |
|
60 |
60 |
$2K |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
125 |
116 |
$2K |
| 93971 |
|
30 |
28 |
$2K |
| 73502 |
|
49 |
49 |
$2K |
| 85652 |
|
672 |
663 |
$2K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
13 |
13 |
$2K |
| 71020 |
|
48 |
39 |
$2K |
| Z7502 |
|
41 |
40 |
$1K |
| 94150 |
|
133 |
106 |
$1K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
41 |
39 |
$1K |
| 76536 |
|
30 |
28 |
$1K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
185 |
182 |
$1K |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
60 |
59 |
$1K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
93 |
87 |
$1K |
| 99152 |
|
17 |
16 |
$1K |
| 87210 |
|
276 |
272 |
$1K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
102 |
84 |
$1K |
| 90715 |
|
24 |
24 |
$1K |
| 82375 |
|
61 |
60 |
$968.14 |
| 90656 |
|
24 |
24 |
$955.88 |
| 80143 |
|
63 |
62 |
$952.02 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
41 |
40 |
$807.05 |
| 71010 |
|
41 |
33 |
$781.42 |
| 80179 |
|
38 |
38 |
$638.58 |
| 83540 |
|
95 |
93 |
$608.26 |
| 81015 |
|
150 |
133 |
$557.80 |
| 64483 |
|
27 |
27 |
$545.02 |
| 86140 |
|
114 |
106 |
$527.78 |
| 86850 |
|
70 |
70 |
$417.72 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
68 |
63 |
$397.00 |
| 86900 |
|
84 |
82 |
$377.65 |
| 86780 |
|
32 |
32 |
$353.40 |
| 84439 |
|
38 |
38 |
$343.84 |
| 86901 |
|
72 |
70 |
$339.38 |
| 87340 |
|
34 |
33 |
$313.39 |
| 81002 |
|
94 |
87 |
$313.24 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
15 |
14 |
$253.92 |
| 80061 |
Lipid panel |
13 |
13 |
$138.48 |
| 64493 |
|
18 |
15 |
$132.30 |
| 64484 |
|
13 |
13 |
$76.86 |
| 86706 |
|
15 |
15 |
$71.25 |
| 0270 |
|
324 |
152 |
$62.78 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
13 |
13 |
$58.32 |
| J2060 |
Injection, lorazepam, 2 mg |
15 |
12 |
$33.50 |
| 0250R |
|
417 |
260 |
$0.00 |